Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion type Assertion NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_head.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion wasGeneratedBy ECO_0000203 NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_provenance.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion wasDerivedFrom befree-20140225 NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_provenance.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion SIO_000772 20626469 NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_provenance.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion evidence source_evidence_literature NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_provenance.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_provenance.